Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
14.56
+0.19 (+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Macrogenics
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 17, 2023
Via
Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
February 17, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
The Latest Analyst Ratings for Macrogenics
January 19, 2023
Via
Benzinga
7 Analysts Have This to Say About Macrogenics
November 23, 2022
Via
Benzinga
Expert Ratings for Macrogenics
November 23, 2022
Via
Benzinga
What 7 Analyst Ratings Have To Say About Macrogenics
November 23, 2022
Via
Benzinga
Where Macrogenics Stands With Analysts
November 23, 2022
Via
Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
February 17, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via
Benzinga
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients
February 14, 2023
Via
Benzinga
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
January 19, 2023
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market...
Via
Benzinga
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying
November 28, 2022
Although US stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Why Shares of MacroGenics Were Dropping Tuesday
November 22, 2022
Profit-taking and an analyst downgrade affected the stock's price.
Via
The Motley Fool
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
November 23, 2022
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.
Via
Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
November 23, 2022
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...
Via
Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
Dow Jumps Over 300 Points; S&P 500 Rises 1%
November 22, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday.
Via
Benzinga
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings
November 22, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday.
Via
Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 22, 2022
Via
Benzinga
US Stocks Open Higher As Dow Surges 250 Points
November 22, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday.
Via
Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
November 18, 2022
Via
Benzinga
Gap, Palo Alto Networks And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 18, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why MacroGenics Stock Crushed the Market on Monday
November 14, 2022
Positive momentum continues for the cancer specialist in the wake of its latest earnings report.
Via
The Motley Fool
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
November 14, 2022
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...
Via
Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
November 11, 2022
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...
Via
Benzinga
Why MacroGenics Stock Popped Again Today
November 07, 2022
Investors and analysts alike are getting more bullish on the company in the wake of its third-quarter results.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.